121![Alzheimer’s Medications: Alzheimer’s Medications:](https://www.pdfsearch.io/img/dca1eb48796d7dc7ad6a052697d63a2f.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-06-05 08:06:32
|
---|
122![Alzheimer’s Medications: Alzheimer’s Medications:](https://www.pdfsearch.io/img/c92ebdb2468cfd172799be279fc1296f.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-05-21 21:10:49
|
---|
123![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL (lanthanum carbonate) Chewa HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL (lanthanum carbonate) Chewa](https://www.pdfsearch.io/img/f7af1dcf81d0aed7b9023e8cc9e15459.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-09-07 15:08:27
|
---|
124![CDER New Molecular Entity (NME) Drug and New Biologic Approvals for Calendar Year 2008 Updated through December 31, 2008 NME New Drug Application (NDA) Approvals: Application Type CDER New Molecular Entity (NME) Drug and New Biologic Approvals for Calendar Year 2008 Updated through December 31, 2008 NME New Drug Application (NDA) Approvals: Application Type](https://www.pdfsearch.io/img/292222c704bda14c86bedf69f26d281d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
125![New Drug Application (NDA) & Biologic License Application (BLA) Efficacy Supplement Calendar Year Approvals As of December 31, 2012 Selection Criteria: User Response: Start Date: [removed]End Date: [removed] New Drug Application (NDA) & Biologic License Application (BLA) Efficacy Supplement Calendar Year Approvals As of December 31, 2012 Selection Criteria: User Response: Start Date: [removed]End Date: [removed]](https://www.pdfsearch.io/img/0a38996edba19207f3a35cb15540e50d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
126![Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement](https://www.pdfsearch.io/img/362612d233fb3adcd7549396d587ba6e.jpg) | Add to Reading ListSource URL: www.janssen.comLanguage: English - Date: 2014-07-31 20:38:04
|
---|
127![HIGHLIGHTS OF PRESCRIBING INFORMATION[removed]DOSAGE FORMS AND STRENGTHS[removed]These highlights do not include all the information needed to • HIGHLIGHTS OF PRESCRIBING INFORMATION[removed]DOSAGE FORMS AND STRENGTHS[removed]These highlights do not include all the information needed to •](https://www.pdfsearch.io/img/475aa402ccb32803f1448d88abdb1ea0.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-07-07 17:17:35
|
---|
128![HIGHLIGHTS OF PRESCRIBING INFORMATION[removed]DOSAGE FORMS AND STRENGTHS[removed]These highlights do not include all the information needed to • HIGHLIGHTS OF PRESCRIBING INFORMATION[removed]DOSAGE FORMS AND STRENGTHS[removed]These highlights do not include all the information needed to •](https://www.pdfsearch.io/img/79fba501a07604e9aee106b1b2e04ffd.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-08-30 08:36:08
|
---|
129![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-r HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-r](https://www.pdfsearch.io/img/0f0a078307f8d642a15f9cb6273bfaca.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-11-01 16:25:04
|
---|
130![Microsoft Word - Tapentadol_ ERTabs_200533_RC09-10.doc Microsoft Word - Tapentadol_ ERTabs_200533_RC09-10.doc](https://www.pdfsearch.io/img/6986826bc060e75e715fdb9dbf3aa4d1.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|